This announcement is a separate document:
復星醫藥：於二零二二年八月十日（星期三）舉行的二零二二年第一次臨時股東大會所提呈決議案的投票結果及選舉執行董事
FOSUN PHARMA: POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, 10 AUGUST 2022 AND ELECTION OF EXECUTIVE DIRECTOR
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.